Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-122 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy VolunteersClinicalTrials.gov · 2026-06-04The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Molecular psychiatry · 2026-05-29Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-28Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-12Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-ControlClinicalTrials.gov · 2026-05-04PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures.Journal of psychopharmacology (Oxford, England) · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain modelsStanford Digital Repository · 2026-04-30A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.International journal of molecular sciences · 2026-03-20A fungus among us: investigating queensland’s largest magic mushroom growing operationAustralian Journal of Forensic Sciences · 2026-03-16Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.ACS pharmacology & translational science · 2026-03-13Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant responsebioRxiv · 2026-03-10A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-03-03Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic PainThe Journal of Pain · 2026-03-01Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-02-12Compassionate use of psilocybin for treatment-resistant depression in Germany.The lancet. Psychiatry · 2026-02-01No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain.Nature communications · 2026-01-22Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-21Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02Sex-dependent effects of psychedelics: review of evidence from rodent models.Frontiers in psychiatry · 2026-01-01Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.Journal of addiction medicine · 2026-01-01Retraction: Acute psilocybin increased cortical activities in rats.Frontiers in neuroscience · 2026-01-01Marketing by online tobacco retailers: An observational cross-sectional study.Tobacco induced diseases · 2026-01-01Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-09Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive DisorderClinicalTrials.gov · 2025-11-26Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-21Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical sciences (Basel, Switzerland) · 2025-11-20Salience, sensemaking, and setting in psilocybin microdosingRepository of the University of Ljubljana (University of Ljubljana) · 2025-11-18CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.Molecular neurobiology · 2025-11-01Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-17Psilocybin-assisted psychotherapy in adults with depression - A literature review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication StudyResearch Square · 2025-09-25Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and RatsBiological Psychiatry Global Open Science · 2025-09-01A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderClinicalTrials.gov · 2025-08-19363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIORThe international journal of neuropsychopharmacology · 2025-08-01Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.Psychiatry and clinical psychopharmacology · 2025-07-30ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.Pharmacological research · 2025-05-01Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-04-01Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-06Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report.Psychiatry research · 2025-03-01Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEWHealth Problems of Civilization · 2025-02-20Psychedelic Information TheoryProceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI · 2025-02-06Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.Psychopharmacology bulletin · 2025-02-03Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-16Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.European psychiatry: the journal of the Association of European Psychiatrists · 2025-01-10Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder.Psychedelics · 2025-01-01Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025-01-01Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.Deutsches Arzteblatt international · 2024-12-27Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating DisorderClinicalTrials.gov · 2024-11-19Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.The European journal of neuroscience · 2024-11-01The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive EnhancementMiddle East Research Journal of Biological Sciences · 2024-09-28Distinct classes of antidepressants commonly act to shape pallidal structure and function in micebioRxiv · 2024-09-24[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].Der Nervenarzt · 2024-09-01The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or settingmedRxiv · 2024-08-26Psilocybin, moralization and psychotherapy: a scoping review and a case reportPhilosophical Psychology · 2024-08-20Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.JAMA psychiatry · 2024-06-01Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.bioRxiv: the preprint server for biology · 2024-06-01Psilocybin as a new way for depression treatmentJournal of Education Health and Sport · 2024-05-15From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream MedicineEuropean Journal of Arts Humanities and Social Sciences · 2024-05-01Psilocybin poisoning from Psilocybe argentipes ingestionVisual Journal of Emergency Medicine · 2024-03-11Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08The development of psilocybin therapy for treatment-resistant depression: an update.BJPsych bulletin · 2024-02-01Neural effects of psilocybin-treatment in patients with treatment-resistant depressionNeuroscience Applied · 2024-01-01Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Neuropsychiatric disease and treatment · 2024-01-01Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.ClinicalTrials.gov · 2023-12-26Statistical diversity distinguishes global states of consciousnessbioRxiv · 2023-12-07DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?IBRO Neuroscience Reports · 2023-10-01Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-09-01Psilocybin und Funktionalität bei DepressionInFo Neurologie + Psychiatrie · 2023-08-01In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.Journal of psychiatric research · 2023-05-01347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-10The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.International journal of molecular sciences · 2023-01-10Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational InsightsChemistrySelect · 2023-01-09Italian psychedelic therapies of the past century: An historical overviewDrug Science Policy and Law · 2023-01-01Psilocin - The “real deal” or an extraction byproductJournal of Forensic Sciences · 2023-01-01Conformational Landscape and Properties of Psilocybin: A Computational ApproachChemistrySelect · 2022-10-04Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insightsAuthorea Preprints · 2022-09-01Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of personalized medicine · 2022-06-19Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant DepressionClinicalTrials.gov · 2022-05-20Psilocybin-induced takotsubo cardiomyopathy.BMJ case reports · 2022-05-17Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Cureus · 2022-05-01Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.Fungal biology · 2022-04-01Unravelling a New Conformer of Psilocin Through Computational MethodsSSRN Electronic Journal · 2022-01-01[Treatment-resistant depression. From classification to new therapies.].Rivista di psichiatria · 2022-01-01Conformational Analysis of Psilocybin: A Computational ApproachSSRN Electronic Journal · 2021-12-31Derivatization-assisted enzyme-linked immunosorbent assay for identifying hallucinogenic mushrooms with enhanced sensitivity.Analytical methods: advancing methods and applications · 2021-09-16Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.Molecules (Basel, Switzerland) · 2021-04-22O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depressionBrazilian Journal of Health Review · 2021-04-19Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2021-02-03Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.Pharmacological reviews · 2021-01-01Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.Frontiers in pharmacology · 2021-01-01The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-03Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushroomsJournal of Pharmaceutical and Biomedical Analysis · 2020-10-01Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.Expert review of clinical pharmacology · 2020-08-01[Addictions].Revue medicale suisse · 2020-01-15Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-01-13The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.Frontiers in pharmacology · 2020-01-01Disruptive Psychopharmacology.JAMA Psychiatry · 2019-07-30Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushroomsClinica Chimica Acta · 2019-06-01Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018-07-17Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-02-01d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.Progress in brain research · 2018-01-01Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG studyEuropean Neuropsychopharmacology · 2016-10-01ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.ChemInform · 2016-07-01PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe international journal of neuropsychopharmacology · 2016-05-27PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe international journal of neuropsychopharmacology · 2016-05-27PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotoninTetrahedron · 2016-05-01Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and PsilocinJournal of Analytical & Bioanalytical Techniques · 2015-01-01Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake RatsBiological ^|^ Pharmaceutical Bulletin · 2015-01-01Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are OverratedTherapeutic Drug Monitoring · 2014-02-01Fungal Hallucinogens Psilocin, Ibotenic Acid, and MuscimolTherapeutic Drug Monitoring · 2013-08-01Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2012-02-01GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine · 2009-04-01[Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan].Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology · 2009-03-01Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and NeurogenesisDigital Commons - University of South Florida (University of South Florida) · 2007-12-31The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2007-09-01Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, PsilocinJournal of Health Science · 2004-01-01Morphological and chemical analysis of magic mushrooms in Japan.Forensic science international · 2003-12-17The examination of mushroom poisonings at Akita University.Legal medicine (Tokyo, Japan) · 2003-03-01ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.ChemInform · 2002-07-23Drugs of abuse monitoring in blood for control of driving under the influence of drugs.Therapeutic drug monitoring · 2002-04-01Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.Chemical and Pharmaceutical Bulletin · 2002-01-01ChemInform Abstract: Chemistry of Indoles. Part 88. A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde.ChemInform · 1999-06-08A Five-Step Synthesis of Psilocin from Indole-3-carbaldehydeHETEROCYCLES · 1997-12-31Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.Journal of American college health: J of ACH · 1994-05-01[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica · 1988-01-01Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.The Tohoku journal of experimental medicine · 1986-01-01The effects of psilocybin on EEG and behaviour in monkeys.Activitas nervosa superior · 1974-03-01[Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].Nihon yakurigaku zasshi. Folia pharmacologica Japonica · 1968-03-01[Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].Nihon yakurigaku zasshi. Folia pharmacologica Japonica · 1968-03-01Some biochemical studies on psilocybin and psilogin.Journal of neuropsychiatry · 1963-04-01Dephosphorylation of psilocybin in the intact mouse.Toxicology and applied pharmacology · 1962-11-01The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.Biochemical pharmacology · 1961-07-01Dephosphorylation of psilocybin to psilocin by alkaline phosphatase.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) · 1961-01-01